Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Profit Beats Estimates on Plavix, HIV Treatments
Bloomberg
Thursday, July 22, 2010 - 8:44am
tags:
earnings, Bristol-Myers Squibb
Lilly Boosts Forecast After Topping Analyst Estimates
Bloomberg
Thursday, July 22, 2010 - 8:44am
tags:
Eli Lilly, earnings
15% Revenue Growth Is Good for Pfizer, but Not Gilead
Motley Fool
Thursday, July 22, 2010 - 8:43am
tags:
Pfizer, Gilead Sciences, earnings, JNJ, Bristol-Myers Squibb, Merck
FDA Halts A Controversial Avandia Study
Pharmalot
Wednesday, July 21, 2010 - 4:52pm
tags:
FDA, GSK, Avandia, clinical trials, diabetes
New FDA report shows multiple lapses at J&J plant
Yahoo/AP
Wednesday, July 21, 2010 - 4:51pm
tags:
FDA, recalls, JNJ
FDA Panel Members Talk About Avandia Conflicts
Pharmalot
Wednesday, July 21, 2010 - 3:59pm
tags:
FDA, GSK, Avandia, diabetes, advisory panels
Glaxo takes new AIDS drug into final-stage tests
Reuters
Wednesday, July 21, 2010 - 3:56pm
tags:
AIDS, HIV, GSK, Shionogi
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wednesday, July 21, 2010 - 3:55pm
tags:
obesity, Vivus, Qnexa, FDA, Arena Pharmaceuticals, Contrave, Orexigen
Pfizer: Warming Up or Cooling Off?
Motley Fool
Wednesday, July 21, 2010 - 3:54pm
tags:
Pfizer
Genzyme Reports Financial Results for the Second Quarter of 2010
Yahoo
Wednesday, July 21, 2010 - 8:52am
tags:
earnings, Genzyme
J&J’s 2010 Price Tag for Recalls: $600 Million. But What About Reputation?
WSJ Online
Wednesday, July 21, 2010 - 8:48am
tags:
JNJ, recalls
Abbott Q2 net income flat, sales rise 18%
Marketwatch
Wednesday, July 21, 2010 - 8:17am
tags:
Abbott Laboratories, earnings
FTC's Heart May Be in Right Place on High Drug Prices, but Its Logic Is Not
BNET Pharma
Wednesday, July 21, 2010 - 8:07am
tags:
FTC, drug pricing
Teva Agrees To End IP Suit Over Aricept Patent
Forbes
Wednesday, July 21, 2010 - 8:03am
tags:
Teva Pharmaceuticals, lawsuits, Aricept, Alzheimer's disease, generics, Eisai
GlaxoSmithKline posts quarterly loss after charges
Marketwatch
Wednesday, July 21, 2010 - 8:01am
tags:
GSK, earnings
Gilead Drops on Q2 Miss; Some HIV Drugs Decline
Bizjournals.com
Wednesday, July 21, 2010 - 8:01am
tags:
Gilead Sciences, earnings
Lilly Announces Completion of Alnara Acquisition
Yahoo
Wednesday, July 21, 2010 - 8:00am
tags:
Eli Lilly, M&A, Alnara
Avastin Breast Cancer Vote Signals Tough Environment For Drug Companies
Forbes
Wednesday, July 21, 2010 - 7:59am
tags:
Roche, breast cancer, Avastin, targeted therapeutics, cancer
Why Are Pfizer's Shares Down on an Up Day?
Motley Fool
Tuesday, July 20, 2010 - 6:08pm
tags:
Pfizer, tanezumab
Johnson & Johnson Gets Subpoena Over Recalls
Pharmalot
Tuesday, July 20, 2010 - 3:58pm
tags:
JNJ, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.